Tilray Inc (NASDAQ:TLRY)

48.97
Delayed Data
As of Apr 18
 -1.71 / -3.37%
Today’s Change
20.10
Today|||52-Week Range
300.00
-30.58%
Year-to-Date

Today’s Trading

Previous close50.68
Today’s open52.08
Day’s range48.34 - 52.55
Volume1,931,623
Average volume (3 months)2,459,169
Market cap$5.1B
Data as of 4:00pm ET, 04/18/2019

Growth & Valuation

Earnings growth (last year)-873.51%
Earnings growth (this year)-40.70%
Earnings growth (next 5 years)--
Revenue growth (last year)+110.00%
P/E ratioNM
Price/Sales--
Price/Book24.94

Competitors

 Today’s
change
Today’s
% change
ONCESpark Therapeutics I...-0.09-0.08%
NKTRNektar Therapeutics+0.49+1.57%
BPMCBlueprint Medicines ...+0.12+0.16%
ALLOAllogene Therapeutic...+0.39+1.53%
Data as of 4:00pm ET, 04/18/2019

Financials

Next reporting dateMay 29, 2019
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$43.1M
Annual profit (last year)-$67.7M
Net profit margin-157.02%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Brendan Kennedy
Executive Vice President-
Operations
Greg Christopher
Corporate headquarters
Nanaimo, British Columbia

Forecasts